Sikiric, P., et al., A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridine
Some peptides are not available in oral forms or are not as effective
[5] The most scientifically cautious interpretation is not that broad off-target inhibition has been proven, but that broader non-target effects cannot be excluded when experiments use high concentrations, long exposure windows, sensitive cell systems, or designs lacking orthogonal NNMT validation
The first one focuses on systemic health
In the pivotal Fracture Prevention Trial, teriparatide at 20 mcg daily reduced vertebral fracture risk by 65% and nonvertebral fracture risk by 35% over approximately 20 months